Cargando…

Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis

BACKGROUND: Modern high-throughput genomic technologies represent a comprehensive hallmark of molecular changes in pan-cancer studies. Although different cancer gene signatures have been revealed, the mechanism of tumourigenesis has yet to be completely understood. Pathways and networks are importan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cava, Claudia, Bertoli, Gloria, Colaprico, Antonio, Olsen, Catharina, Bontempi, Gianluca, Castiglioni, Isabella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Methodology Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756345/ https://www.ncbi.nlm.nih.gov/pubmed/29304754 http://dx.doi.org/10.1186/s12864-017-4423-x

Ejemplares similares

Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer
por: Colaprico, Antonio, et al.
Publicado: (2015)

In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer
por: Cava, Claudia, et al.
Publicado: (2018)

How interacting pathways are regulated by miRNAs in breast cancer subtypes
por: Cava, Claudia, et al.
Publicado: (2016)

SpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA Data
por: Cava, Claudia, et al.
Publicado: (2017)

Interpreting pathways to discover cancer driver genes with Moonlight
por: Colaprico, Antonio, et al.
Publicado: (2020)

Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential
por: Cava, Claudia, et al.
Publicado: (2015)

In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition
por: Cava, Claudia, et al.
Publicado: (2018)

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
por: Colaprico, Antonio, et al.
Publicado: (2016)

A protein interaction map identifies existing drugs targeting SARS-CoV-2
por: Cava, Claudia, et al.
Publicado: (2020)

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016)

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
por: Bertoli, Gloria, et al.
Publicado: (2015)

Portrait of Tissue-Specific Coexpression Networks of Noncoding RNAs (miRNA and lncRNA) and mRNAs in Normal Tissues
por: Cava, Claudia, et al.
Publicado: (2019)

In Silico Discovery of Candidate Drugs against Covid-19
por: Cava, Claudia, et al.
Publicado: (2020)

Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation
por: Cava, Claudia, et al.
Publicado: (2021)

In Silico Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential Diagnosis
por: Gallivanone, Francesca, et al.
Publicado: (2019)

New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx
por: Mounir, Mohamed, et al.
Publicado: (2019)

Minor Allele Frequencies and Molecular Pathways Differences for SNPs Associated with Amyotrophic Lateral Sclerosis in Subjects Participating in the UKBB and 1000 Genomes Project
por: D’Antona, Salvatore, et al.
Publicado: (2021)

Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction
por: Santo, Giulia Dal, et al.
Publicado: (2022)

TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages
por: Silva, Tiago C., et al.
Publicado: (2016)

Potential Role of miRNAs as Theranostic Biomarkers of Epilepsy
por: Cava, Claudia, et al.
Publicado: (2018)

Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition
por: Cava, Claudia, et al.
Publicado: (2014)

MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration
por: Bertoli, Gloria, et al.
Publicado: (2016)

Identification of Breast Cancer Subtype-Specific Biomarkers by Integrating Copy Number Alterations and Gene Expression Profiles
por: Cava, Claudia, et al.
Publicado: (2021)

Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activity
por: Pavel, Ana B., et al.
Publicado: (2016)

Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
por: Cantini, Laura, et al.
Publicado: (2019)

Pan-cancer analysis of differential DNA methylation patterns
por: Shi, Mai, et al.
Publicado: (2020)

Patient-Specific Network for Personalized Breast Cancer Therapy with Multi-Omics Data
por: Cava, Claudia, et al.
Publicado: (2021)

Theranostic application of miR-429 in HER2+ breast cancer
por: Cava, Claudia, et al.
Publicado: (2020)

Identifying related cancer types based on their incidence among people with multiple cancers
por: Bajdik, Chris D, et al.
Publicado: (2006)

Identification of collaborative driver pathways in breast cancer
por: Liu, Yang, et al.
Publicado: (2014)

Discovery of co-occurring driver pathways in cancer
por: Zhang, Junhua, et al.
Publicado: (2014)

A versatile web app for identifying the drivers of COVID-19 epidemics
por: Getz, Wayne M., et al.
Publicado: (2021)

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021)

Identifying candidate drivers of drug response in heterogeneous cancer by mining high throughput genomics data
por: Nabavi, Sheida
Publicado: (2016)

Study of Meta-analysis strategies for network inference using information-theoretic approaches
por: Pham, Ngoc C., et al.
Publicado: (2017)

Integrated Mobile Element Scanning (ME-Scan) method for identifying multiple types of polymorphic mobile element insertions
por: Loh, Jui Wan, et al.
Publicado: (2020)

Leveraging protein quaternary structure to identify oncogenic driver mutations
por: Ryslik, Gregory A., et al.
Publicado: (2016)

A pan-cancer somatic mutation embedding using autoencoders
por: Palazzo, Martin, et al.
Publicado: (2019)

Improving pan-genome annotation using whole genome multiple alignment
por: Angiuoli, Samuel V, et al.
Publicado: (2011)

PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
por: Ali, Mohamad Moustafa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kivora2a2pa17n1j079c3g8agb